Zydus Lifesciences launches generic drug for overactive bladder in US mkt
The company is also preparing to launch the 50 mg tablets in the market, it added | Photo: X@ZydusUniverse 2
Continue readingThe Number One Finance & Business Blog!
The company is also preparing to launch the 50 mg tablets in the market, it added | Photo: X@ZydusUniverse 2
Continue readingSun Pharmaceuticals said on Tuesday it has entered into a licensing agreement with Philogen SpA to market a skin cancer
Continue readingSun Pharmaceuticals said Saturday that it has proposed the full acquisition of Israel-based Taro Pharmaceuticals through a reverse triangle merger.
Continue reading